Experienced in Retinal Detachment

Dr. Mujtaba A. Qazi

Ophthalmology
Pepose Vision Institute PC
1815 Clarkson Rd, 
Chesterfield, MO 
Experienced in Retinal Detachment
Pepose Vision Institute PC
1815 Clarkson Rd, 
Chesterfield, MO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mujtaba Qazi is an Ophthalmologist in Chesterfield, Missouri. Dr. Qazi is rated as an Experienced provider by MediFind in the treatment of Retinal Detachment. His top areas of expertise are Cataract, Keratoconus, Dry Eye Syndrome, Corneal Transplant, and Cataract Removal.

His clinical research consists of co-authoring 8 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Ophthalmology
Licenses
Ophthalmology in MO
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Celtic
  • HMO
  • INSURANCE PLAN
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Home State Health
  • EPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetLife
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 18 Less Insurance Carriers -

Locations

PEPOSE VISION INSTITUTE PC
1815 Clarkson Rd, Chesterfield, MO 63017

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Multicenter, Randomized, Double-Masked Study To Evaluate The Safety, Tolerability, And Efficacy Of SURF-100 Ophthalmic Solution (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination) In Subjects With Dry Eye Disease
A Multicenter, Randomized, Double-Masked Study To Evaluate The Safety, Tolerability, And Efficacy Of SURF-100 Ophthalmic Solution (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination) In Subjects With Dry Eye Disease
Enrollment Status: Completed
Publish Date: May 11, 2025
Intervention Type: Drug
Study Drugs: Combination of Mycophenolic Acid and Betamethasone Sodium Phosphate, Mycophenolic Acid, Restasis Ophthalmic Emulsion, Xiidra Ophthalmic Solution
Study Phase: Phase 2
A Prospective, Randomized, Controlled, Double-Masked, Phased, Multi-Center Clinical Study to Evaluate the Safety and Efficacy of the LensGen® Juvene® Intraocular Lens
A Prospective, Randomized, Controlled, Double-Masked, Phased, Multi-Center Clinical Study to Evaluate the Safety and Efficacy of the LensGen® Juvene® Intraocular Lens
Enrollment Status: Not_yet_recruiting
Publish Date: March 09, 2023
Intervention Type: Device
Study Phase: Not Applicable
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
Enrollment Status: Completed
Publish Date: October 24, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to PVP-Iodine and Placebo in the Treatment of Adenoviral Conjunctivitis
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to PVP-Iodine and Placebo in the Treatment of Adenoviral Conjunctivitis
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in the Treatment of Bacterial Conjunctivitis
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in the Treatment of Bacterial Conjunctivitis
Enrollment Status: Completed
Publish Date: June 09, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Enrollment Status: Completed
Publish Date: February 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

8 Total Publications

Association of Treatment Duration and Clinical Outcomes in Dry Eye Treatment with Sutureless Cryopreserved Amniotic Membrane.
Association of Treatment Duration and Clinical Outcomes in Dry Eye Treatment with Sutureless Cryopreserved Amniotic Membrane.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: June 16, 2023
Similar Doctors
Elite in Retinal Detachment
Dr. Daniel P. Joseph
Ophthalmology
Elite in Retinal Detachment
Dr. Daniel P. Joseph
Ophthalmology
8820 Ladue Rd Ste 203, 
Saint Louis, MO 
 (10.3 miles away)
314-367-1181
Languages Spoken:
English
See accepted insurances

Daniel Joseph is an Ophthalmologist in Saint Louis, Missouri. Dr. Joseph is rated as a Distinguished provider by MediFind in the treatment of Retinal Detachment. His top areas of expertise are Retinal Detachment, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Vitrectomy.

Distinguished in Retinal Detachment
Dr. Bradley T. Smith
Ophthalmology
Distinguished in Retinal Detachment
Dr. Bradley T. Smith
Ophthalmology

Retina Consultants Ltd

12106 Tesson Ferry Rd, 
Saint Louis, MO 
 (13.9 miles away)
314-367-1181
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Bradley Smith is an Ophthalmologist in Saint Louis, Missouri. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of Retinal Detachment. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, and Melanoma of the Eye. Dr. Smith is currently accepting new patients.

Distinguished in Retinal Detachment
Dr. Robert J. Olk
Ophthalmology
Distinguished in Retinal Detachment
Dr. Robert J. Olk
Ophthalmology

Retina Center PC

11710 Old Ballas Rd, Suite 102, 
Saint Louis, MO 
 (7.2 miles away)
314-569-2020
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robert Olk is an Ophthalmologist in Saint Louis, Missouri. Dr. Olk is rated as a Distinguished provider by MediFind in the treatment of Retinal Detachment. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Retinal Detachment. Dr. Olk is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Qazi's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 33 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile